Moreover, these studies may inadvertently provide a mechanistic endorsement of upgrading to CNS WHO grade 4 of IDH-mutant astrocytoma harboring CDKN2A/B homozygous deletion. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).